Report ID: SQMIG35A2568
Report ID:
SQMIG35A2568 |
Region:
Global |
Published Date: March, 2024
Pages:
219
|
Tables:
63 |
Figures:
75
In March 2024, the FDA granted clearance to the Dexcom Stelo Glucose Biosensor System, stamping it as the main over-the-counter (OTC) continuous glucose monitor (CGM) to get such an endorsement. This incorporated CGM is intended for grown-ups aged 18 years and more seasoned who don't utilize insulin or for people without diabetes trying to acquire experiences into what diet and exercise mean for blood glucose levels.
In January 2024, the National Research Foundation, Singapore (NRF), granted a S$20 million fund to Nanyang Mechanical University, Singapore, and Imperial College London. The grant plans to help the advancement of strategies to upgrade the security of health information and wearable gadgets.
In January 2024, Kakao Healthcare CEO Hwang Hee declared the launch of PASTA, another portable blood sugar management service, at the J.P. Morgan Healthcare Conference 2024 Created in a joint effort with Dexcom, Novo Nordisk, and I-SENS, PASTA offers highlights like AI-based food acknowledgment, real-time blood sugar measurement, direction, analytical reports, and a local area stage for sharing information.
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONWant to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: SQMIG35A2568